Autoimmune Polyarthritis Induced by Cancer Immunotherapy With Checkpoint Inhibitor

J Clin Rheumatol. 2017 Jun;23(4):235. doi: 10.1097/RHU.0000000000000525.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized* / administration & dosage
  • Antibodies, Monoclonal, Humanized* / adverse effects
  • Antineoplastic Agents, Immunological / administration & dosage
  • Antineoplastic Agents, Immunological / adverse effects
  • Antirheumatic Agents / administration & dosage*
  • Arthritis* / diagnosis
  • Arthritis* / drug therapy
  • Arthritis* / etiology
  • Arthritis* / immunology
  • Autoimmune Diseases / chemically induced
  • Autoimmune Diseases / diagnosis
  • Autoimmune Diseases / physiopathology
  • Autoimmunity / drug effects*
  • Autoimmunity / immunology
  • Drug Monitoring / methods
  • Female
  • Humans
  • Immunotherapy / adverse effects
  • Immunotherapy / methods
  • Medication Therapy Management
  • Melanoma* / drug therapy
  • Melanoma* / pathology
  • Middle Aged
  • Neoplasm Staging
  • Programmed Cell Death 1 Receptor / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents, Immunological
  • Antirheumatic Agents
  • Programmed Cell Death 1 Receptor
  • pembrolizumab